The hsa-mir-483 is located within intron 2 of the IGF2 locus. We found that the mature microRNA (miRNA) miR-483-3p is over-expressed in 100% of Wilms' tumors. In addition, colon, breast and liver cancers exhibit high or even extremely high levels of miR-483-3p in about 30% of the cases. A co-regulation with IGF2 mRNA was detected, although some tumors exhibited high expression of miR-483-3p without a concomitant increase of IGF2. These findings suggested that miR-483-3p could cooperate with IGF2 or act as an autonomous oncogene. Indeed, here we prove that an anti-microRNA oligonucleotide (AMO) against miR-483-3p could inhibit the miRNA without affecting IGF2 mRNA and it could suppress tumorigenicity of HepG2 cells, a cell line that over-expresses miR-483-3p and IGF2. Conversely, no anti-tumor effect was elicited by inhibition of IGF2. The oncogenic mechanism of miR-483-3p was at least partially clarified by the finding that it can modulate the pro-apoptotic protein BBC3/PUMA and miR-483-3p enforced expression could protect cells from apoptosis. Our results indicate that miR-483-3p can function as an anti-apoptotic oncogene in various human cancers and reveal a new potentially important target for anti-cancer therapy.

Oncogenic role of miR-483-3p at the IGF2/483 locus

VERONESE, Angelo;LUPINI, Laura;FERRACIN, Manuela;LANZA, Giovanni;QUERZOLI, Patrizia;CROCE, Carlo Maria;NEGRINI, Massimo
2010

Abstract

The hsa-mir-483 is located within intron 2 of the IGF2 locus. We found that the mature microRNA (miRNA) miR-483-3p is over-expressed in 100% of Wilms' tumors. In addition, colon, breast and liver cancers exhibit high or even extremely high levels of miR-483-3p in about 30% of the cases. A co-regulation with IGF2 mRNA was detected, although some tumors exhibited high expression of miR-483-3p without a concomitant increase of IGF2. These findings suggested that miR-483-3p could cooperate with IGF2 or act as an autonomous oncogene. Indeed, here we prove that an anti-microRNA oligonucleotide (AMO) against miR-483-3p could inhibit the miRNA without affecting IGF2 mRNA and it could suppress tumorigenicity of HepG2 cells, a cell line that over-expresses miR-483-3p and IGF2. Conversely, no anti-tumor effect was elicited by inhibition of IGF2. The oncogenic mechanism of miR-483-3p was at least partially clarified by the finding that it can modulate the pro-apoptotic protein BBC3/PUMA and miR-483-3p enforced expression could protect cells from apoptosis. Our results indicate that miR-483-3p can function as an anti-apoptotic oncogene in various human cancers and reveal a new potentially important target for anti-cancer therapy.
Veronese, Angelo; Lupini, Laura; Consiglio, J.; Visone, R.; Ferracin, Manuela; Fornari, F.; Zanesi, N.; Alder, H.; D'Elia, G.; Gramantieri, L.; Bolondi, L.; Lanza, Giovanni; Querzoli, Patrizia; Angioni, A.; Croce, Carlo Maria; Negrini, Massimo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11392/1386797
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 170
  • ???jsp.display-item.citation.isi??? 162
social impact